![Figure 5, Opioid Agonist Therapy vs. Placebo/No Medication—Retention in Treatment - Interventions for Unhealthy Drug Use—Supplemental Report: A Systematic Review for the U.S. Preventive Services Task Force - NCBI Bookshelf Figure 5, Opioid Agonist Therapy vs. Placebo/No Medication—Retention in Treatment - Interventions for Unhealthy Drug Use—Supplemental Report: A Systematic Review for the U.S. Preventive Services Task Force - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK558210/bin/ch3f4.jpg)
Figure 5, Opioid Agonist Therapy vs. Placebo/No Medication—Retention in Treatment - Interventions for Unhealthy Drug Use—Supplemental Report: A Systematic Review for the U.S. Preventive Services Task Force - NCBI Bookshelf
![Coding strategy for surface luminance switches in the primary visual cortex of the awake monkey | Nature Communications Coding strategy for surface luminance switches in the primary visual cortex of the awake monkey | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27892-3/MediaObjects/41467_2021_27892_Fig1_HTML.png)
Coding strategy for surface luminance switches in the primary visual cortex of the awake monkey | Nature Communications
![Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01937-6/MediaObjects/41591_2022_1937_Fig1_HTML.png)
Individualized, heterologous chimpanzee adenovirus and self-amplifying mRNA neoantigen vaccine for advanced metastatic solid tumors: phase 1 trial interim results | Nature Medicine
![CBS Sports on Twitter: "The “We Let the Dawgs Out” program in Athens, Georgia creates amazing bulldog artwork in support of UGA, while also making important charitable contributions. We learned all about CBS Sports on Twitter: "The “We Let the Dawgs Out” program in Athens, Georgia creates amazing bulldog artwork in support of UGA, while also making important charitable contributions. We learned all about](https://pbs.twimg.com/media/EFAdif5U0AANToS.jpg:large)
CBS Sports on Twitter: "The “We Let the Dawgs Out” program in Athens, Georgia creates amazing bulldog artwork in support of UGA, while also making important charitable contributions. We learned all about
![INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND.... EHA Library. Ravandi-Kashani F. Jun 10 2022; 357228 INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND.... EHA Library. Ravandi-Kashani F. Jun 10 2022; 357228](https://library.ehaweb.org/image/abstract/eha_2022/eha-1940.jpg)
INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND.... EHA Library. Ravandi-Kashani F. Jun 10 2022; 357228
2.2 Å Cryo-EM Tetra-Protofilament Structure of the Hamster Prion 108–144 Fibril Reveals an Ordered Water Channel in the Center | Journal of the American Chemical Society
![Structural library and visualization of endogenously oxidized phosphatidylcholines using mass spectrometry-based techniques | Nature Communications Structural library and visualization of endogenously oxidized phosphatidylcholines using mass spectrometry-based techniques | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26633-w/MediaObjects/41467_2021_26633_Fig1_HTML.png)
Structural library and visualization of endogenously oxidized phosphatidylcholines using mass spectrometry-based techniques | Nature Communications
![Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children | Nature Immunology Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children | Nature Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41590-022-01367-z/MediaObjects/41590_2022_1367_Fig1_HTML.png)